Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Pilot Study of the Effect of Rifaximin on B-Cell Dysregulation in Cirrhosis Due to Chronic Hepatitis C Infection

NCT01951209 is registered in ClinicalTrials.gov with David E. Kaplan, MD MSc as lead sponsor.

NCT NCT01951209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01951209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Pilot Study of the Effect of Rifaximin on B-Cell Dysregulation in Cirrhosis Due to Chronic Hepatitis C Infection
Lead sponsor
David E. Kaplan, MD MSc
Phase
Not applicable
Overall status
Terminated
Start date
November 17, 2016
Completion date
June 12, 2017
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c, liver cirrhosis